B. Downs

A Novel Precision Approach to Overcome the “Addiction Pandemic” by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration

K. Blum, P. Thanos, R. Badgaiyan, 2021, Journal of personalized medicine.

“Dopamine homeostasis” requires balanced polypharmacy: Issue with destructive, powerful dopamine agents to combat America’s drug epidemic

K. Blum, R. Badgaiyan, D. Baron, 2017, Journal of systems and integrative neuroscience.

In Search of Reward Deficiency Syndrome (RDS)-free Controls: The "Holy Grail" in Genetic Addiction Risk Testing.

K. Blum, T. Simpatico, R. Badgaiyan, 2020, Current psychopharmacology.

Statistical Validation of Risk Alleles in Genetic Addiction Risk Severity (GARS) Test: Early Identification of Risk for Alcohol Use Disorder (AUD) in 74,566 Case–Control Subjects

K. Blum, P. Thanos, R. Badgaiyan, 2022, Journal of personalized medicine.

Predictors of the severity of the gang problem at the local level: an analysis of police perceptions

James F. Quinn, B. Downs, 1994 .

Should We Embrace the Incorporation of Genetically Guided "Dopamine Homeostasis" in the Treatment of Reward Deficiency Syndrome (RSD) as a Frontline Therapeutic Modality?

K. Blum, R. Badgaiyan, D. Baron, 2021, Acta scientific neurology.

Genetic Addiction Risk Score (GARS): Testing For Polygenetic Predisposition and Risk to Reward Deficiency Syndrome (RDS)

K. Blum, F. Fornari, E. Braverman, 2011 .